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:  The synthesis of functionalized oxindoles and benzofuranones via 
oxidation of 2-BMIDA indoles and benzofurans, respectively, is described. 
Interconversion of boron species (BMIDAàBF3K) was necessary to enable 
oxidation and overcome boronic acid stability issues associated with a 
difficult BMIDA hydrolysis. Overall, a robust process was developed that 
allowed access to a small library of oxindole and benzofuranone products and 
facilitated the step-efficient synthesis of biologically-active compounds 
containing the oxindole pharmacophore.	
:   Boron, oxidation, heterocycles, lactams, lactones 
	
The	 oxindole	 motif	 is	 present	 in	 the	 core	 of	 numerous	
biologically	 active	natural	 products	 as	well	 as	 pharmaceuticals	




 1 Pharmaceutically relevant oxindoles. 
The	most	 common	 synthetic	 approaches	 towards	 the	 oxindole	
framework	forge	the	pyrrole	nucleus	either	via	disconnection	at	
the	 amide	C-N	bond	 to	provide	 a	phenylacetic	 acid	precursor,2	
or	 at	 the	 C-3	 position	 to	 afford	 an	 anilide	 precursor	 (Scheme	
1a).3	 Despite	 significant	 research,	 preparation	 of	 oxindoles	
beginning	from	the	corresponding	indole	starting	materials	are	
comparatively	 limited,4	with	 oxidative	methods	 often	 suffering	
from	 the	 problem	 of	 over-oxidation	 to	 deliver	 isatins	 (Scheme	
1b).5	 Hydrolysis	 of	 2-oxy-indoles	 gives	 the	 corresponding	
oxindoles;	however,	 this	 requires	a	pre-oxygenated	 indole	as	a	
starting	material	(Scheme	1c).6	We	recently	disclosed	a	one-pot	
synthesis	 of	 2-heterocyclic	 BMIDA’s,7	 which	 are	 bench	 stable,	
free	 flowing	 solids	 that	 can	 be	 stored	 indefinitely	 without	
degradation.8	 Here	 we	 present	 the	 utility	 of	 2-BMIDA	 indoles	




 Methods for the synthesis of oxindoles. 
Oxidation	 of	 2-borylated	 indoles	 is	 limited	 to	 two	 single	
examples	using	two	specific	2-BPin	indole	substrates.9	This	class	









































a) Buidling the pyrrole nucleus
b) C2-oxidation of indole
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a	 range	of	 solvent/water	mixtures	and	 in	 the	presence	of	base	
(Scheme	2	–	see	Supporting	Information	for	full	details).11	
 
2 Attempted direct hydrolysis/oxidation of 2-BMIDA indole 1. PDB 
= protodeboronation. 
Based	on	the	base	lability	of	BMIDA	and	the	well	studied	slow	or	
fast	 release	of	 the	parent	boronic	 acid,10	we	planned	an	 in	 situ	
hydrolysis	 of	 1	 to	 deliver	 2	 that	 would	 then	 be	 oxidized	 to	
deliver	3a.	 	To	our	surprise,	when	using	a	base/oxidant	system	
of	NaOH/H2O2	at	room	temperature	(fast	hydrolysis	conditions),	
the	 BMIDA	 group	 remained	 intact,	 i.e.	 no	 hydrolysis	 was	
observed,	 even	 in	 the	 presence	 of	 excess	 aq.	 NaOH.	 In	 an	
attempt	to	drive	the	hydrolysis	step,	the	reaction	was	heated	to	
50	 ¡C	 with	 increasing	 quantities	 of	 NaOH.	 However,	 while	
hydrolysis	 could	 be	 induced,	 these	 reactions	 returned	 the	
protodeboronated	product	 4	 in	 quantitative	 yields	 in	 all	 cases,	
presumably	 due	 to	 the	 sensitivity	 of	 2	 under	 these	 reaction	
conditions.	Attempting	to	temper	the	reaction	conditions	using	a	
slow	 hydrolysis	 protocol	 with	 either	 K3PO4	 or	 K2CO3	 in	 the	
presence	of	H2O2	 returned	starting	material	 (1)	only.	Changing	
the	 oxidant	 to	 Oxone®	 had	 a	 small	 positive	 effect	 –	 hydrolysis	




These	 initial	 investigations	 highlighted	 a	 compatibility	 issue	
between	 the	 conditions	 required	 to	 hydrolyze	 the	 BMIDA	 unit	
and	the	stability	of	the	intermediate	boronic	acid	(as	well	as	the	
oxindole	product).	To	overcome	these	issues,	we	postulated	that	
a	 simple	 boron	 species	 interconversion	 process	 might	 be	
achieved	 under	 mild	 reaction	 conditions	 to	 deliver	 an	
organoboron	 derivative	 that	 could	 then	 be	 oxidized	 under	
conditions	 sufficiently	 mild	 to	 inhibit	 degradation	 of	 the	
organoboron	 intermediate	 or	 product.	 In	 particular,	 BMIDA	
species	 can	 be	 converted	 to	 the	 potassium	
organotrifluoroborate	 (BF3K)	 derivative	 under	 relatively	 mild	
reaction	 conditions12	 and	 BF3K	 species	 can	 also	 be	 oxidized	
under	mild	conditions.13	However,	BMIDA-BF3K	interconversion	
on	 this	 template	 was	 unknown.	 Accordingly,	 we	 evaluated	
conversion	of	BMIDA	1	to	the	BF3K	derivative	5.		
 
3 Conversion of BMIDA 1 to BF3K 5. 
A	 short	 survey	 of	 reaction	 conditions	 found	 that	 1	 could	 be	
quantitatively	 converted	 to	5	 upon	 treatment	with	aq.	KHF2	 in	
MeOH	 at	 70	 ¡C	 (Scheme	 3a).	 In	 addition,	 5	 could	 be	
quantitatively	 converted	 to	 the	 desired	 oxindole	 product	 3a	
using	 Oxone®.	 Combining	 these	 two	 events	 proved	 to	 be	
straightforward	 (Table	 1).	 Oxidation	 of	 intermediate	 5	 was	
found	 to	 be	 sluggish	 in	 MeOH;	 however,	 a	 solvent	 switch	 to	
acetone	before	addition	of	the	oxidant	was	more	effective	(entry	
1	 vs.	 entry	 2).	 A	 short	 optimization	 of	 reaction	 time	 and	KHF2	




was	 facile	 with	 Oxone®,	 NaBO3	 and	 H2O2	 were	 ineffective	 for	
oxidation	of	this	intermediate	(entries	6	and	7,	respectively).	
1 Oxidation of Indole BMIDA via speciation 
 
Entry Conditions   (%)
a
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6 aq. KHF2 (5 eq), 4 h/ NaBO3, 4 h
c
 0 









Solvent switch to acetone before addition of Oxidant. 
 
	With	optimum	conditions	in	hand,	the	scope	of	the	reaction	was	
investigated	 by	 application	 to	 a	 range	 of	 substituted	 2-BMIDA	
indole	architectures	(Scheme	4).		
 




H NMR analysis. 
The	reaction	was	found	to	be	tolerant	of	both	electron-donating	


























BF3Kaq. KHF2 (4.5 M), MeOH
1 5: quant.

















i) aq. KHF2 (4.5 M), MeOH
70 ¡C, x h
1 3a


























































i) aq. KHF2 (4.5 M), MeOH
70 ¡C, 4 h
1 3a-l




further	 functionalization	 (3c,	 3d,	 3e,	 3f).	 In	 addition,	
azaindoline	3j	was	delivered	 in	moderate	yield	by	NMR	(42%)	
with	 the	 mass	 balance	 consisting	 of	 the	 product	 of	
protodeboronation.	 However,	 this	 product	 was	 found	 to	 be	
labile	 to	 hydrolysis	 on	 silica.	 The	 N-tosyl	 group	 could	 be	
replaced	with	a	methyl	unit	but	resulted	in	a	decrease	in	yield	of	




In	 keeping	 with	 our	 interests	 in	 medicinal	 chemistry,14	 we	
sought	to	utilize	the	oxindole	products	as	building	blocks	in	the	
synthesis	 of	 biologically	 active	 molecules.	 In	 particular,	 the	
ubiquity	of	the	oxindole	motif	in	kinase	drug	discovery15	 led	us	
to	target	compounds	of	this	class.	First	steps	into	derivatization	
of	 our	 oxindole	 products	 quickly	 identified	 an	 issue	 with	
deprotection	of	the	N-tosyl.	Specifically,	the	lactam	was	found	to	
be	readily	hydrolyzed	under	both	acidic	and	basic	conditions.16	
To	 the	 best	 of	 our	 knowledge,	 no	 methods	 exist	 for	 the	
deprotection	 of	 N-Ts-oxindole,	 although	 sulfonamides	 have	
been	 removed	 from	 C3-substituted	 oxindoles	 using	 several	
approaches.17	 Accordingly,	 we	 surveyed	 reaction	 conditions	




2 Deprotection of N-Ts oxindole . 
 
Entry Conditions 6 (%)
a
 
1 6 M NaOH, 1,4-dioxane, rt 0 
2 1 M NaOH, 1,4-dioxane, rt 0 
3 1 M TBAF, THF, rt 0 
4 Mg, MeOH, rt 0 
5 SmI2, pyrrolidine, H2O, rt 0 




To	 limit	 exposure	 to	 basic	 reaction	 conditions,	 we	 evaluated	
several	 single-electron	methods.	Mg	powder	 in	MeOH	 resulted	
in	solvolysis	of	3a.17b	SmI2	conditions	led	to	full	consumption	of	
the	 starting	material	within	 five	minutes	of	 addition;	however,	
none	 of	 the	 desired	 oxindole	was	 observed,	 delivering	 only	 an	
unidentifiable	mixture	of	products.18	Fortunately,	application	of	
sodium	 naphthalenide	 at	 –78	 ¡C	 provided	 clean	 conversion	 to	
the	desired	oxindole	product	in	90%	isolated	yield.19	
With	effective	conditions	for	the	deprotection	now	available,	we	
were	 able	 to	 prepare	 several	 biologically	 active	 products	
(Scheme	 5	 and	 6).	Both	 the	 natural	 product	 (±)-coerulescine20	
and	 kinase	 inhibitor	 semaxanib21	 could	 be	 quickly	 accessed	
through	 common	 oxindole	 3a	 following	 tosyl	 deprotection	
(Scheme	5).	From	this	common	intermediate,	condensation	with	
commercially	 available	 pyrrole	 7	 afforded	 semaxanib	 in	
excellent	yield,	while	C3	alkylation	followed	by	ring	expansion22	
enabled	 access	 to	 (±)-coerulescine	 in	 moderate	 overall	 yield.	





5 Synthesis of semaxanib and (±)-coerulescine. Isolated yields. 
Tenidap,	a	potent	COX	inhibitor,23	was	efficiently	synthesized	in	
five	steps	from	oxindole	3e	(Scheme	6).	Tosyl	deprotection	gave	
the	 free	 oxindole	 9,	 which,	 upon	 treatment	 with	 phenyl	
chloroformate	followed	by	ammonium	carbonate,	gave	oxindole	
10	 in	 73%	 yield.	 Condensation	 with	 2-thiophenecarbonyl	




6 Synthesis of tenidap. Isolated yields. 
In	 conclusion,	 we	 have	 reported	 a	 novel	 method	 for	 the	
preparation	of	oxindoles	from	2-BMIDA	indoles.	A	boron	species	
(BMIDA	 to	 BF3K)	 interconversion	 was	 used	 to	 overcome	 the	
instability	of	the	intermediate	indole	2-boronic	acid	towards	the	
conditions	 required	 for	 hydrolysis	 of	 an	 unusually	 robust	
BMIDA	 species.	 The	 BF3K	 species	 was	 readily	 oxidized	 to	 the	
corresponding	oxindole	under	mild	conditions	allowing	one-pot	
access	 to	 oxindole	 products.	 The	 scope	 of	 the	 reaction	 was	
evaluated	 by	 application	 towards	 a	 series	 of	 substrates	 and	
further	 exemplified	 in	 the	 context	 of	 the	 synthesis	 of	 kinase	


















































3a:  R = Ts






























3e:  R = Ts




   THF, 0 ¡C
ii) (NH4)2CO3







were	 used	without	 further	 purification	unless	 otherwise	 stated.	Where	
necessary,	purification	was	carried	out	according	to	standard	laboratory	
methods.24	 Reactions	 were	 carried	 out	 using	 conventional	 glassware	
(preparation	of	intermediates)	or	in	capped	5	mL	microwave	vials.	Room	
temperature	 was	 generally	 ca.	 18	 °C.	 Reactions	 were	 carried	 out	 at	
elevated	 temperatures	 using	 a	 temperature-regulated	 hotplate/stirrer.	
Thin	 layer	 chromatography	 was	 carried	 out	 using	 Merck	 silica	 plates	




were	 obtained	 on	 a	 Shimadzu	 IRAffinity-1	 machine.	 19F	 NMR	 spectra	
were	obtained	on	a	Bruker	AV	400	spectrometer	at	376	MHz.	 11B	NMR	
spectra	were	obtained	on	a	Bruker	AV	400	spectrometer	at	128	MHz.	1H	
and	 13C	NMR	 spectra	were	obtained	on	 either	 a	Bruker	AV	400	 at	 400	
MHz	and	125	MHz,	respectively,	or	Bruker	DRX	500	at	500	MHz	and	126	







An	 oven	 dried	 10	mL	microwave	 vial	was	 charged	with	 R-BMIDA	 (0.1	
mmol,	1	equiv)	before	the	addition	of	4	mL	MeOH.	The	vial	was	capped	
before	 the	 addition	 of	 KHF2	 (100	 μL,	 4.5	 M	 aq.	 solution,	 0.5	 mmol,	 5	
equiv).	The	reaction	was	 then	heated	 to	70	°C	 for	4	h.	At	 this	point	 the	
reaction	 was	 cooled,	 vented,	 decapped,	 and	 the	 MeOH	 solution	 was	
transferred	to	a	clean	flask	and	concentrated	under	reduced	pressure	to	
provide	a	white	solid.	The	residue	was	diluted	with	hot	acetone	and	the	





water	 (2	mL)	 and	 extracted	with	 CH2Cl2	 (2×5	mL).	 The	 organics	were	
filtered	through	2	cm	of	silica	gel	and	washed	through	with	a	further	20	
mL	 CH2Cl2.	 The	 resulting	 solution	 was	 concentrated	 under	 vacuum	 to	
afford	the	desired	product.	
1-Tosylindolin-2-one	(3a)	
Prepared	according	 to	 the	 general	procedure	 from	 (1-tosyl-1H-indol-2-






13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 172.3,	 145.2,	 139.9,	 134.8,	 129.3,	 128.1,	
127.5,	124.2,	124.1,	122.7,	113.2,	35.6,	21.2.		
HRMS	 (NSI):	 m/z	 [M+H]+	 calcd	 for	 C15H14NO3S:	 288.0689;	 found:	
288.0690.	
1-Methylindolin-2-one	(3b)	
Prepared	according	 to	 the	general	procedure	 from	(1-methyl-1H-indol-















13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 172.3,	 146.0,	 141.2,	 135.0,	 134.4,	 129.9,	
128.1,	125.5,	125.4,	124.7,	121.5,	114.4,	35.7,	21.7.	










13C	NMR	 (CDCl3,	 101	MHz):	 δ	 172.3,	 159.9	 (d,	 1JC-F	 =	 244.0	 Hz),	 145.8,	
135.1,	 129.8,	 128.0,	 124.9	 (d,	 3JC-F	 =	 8.6	 Hz),	 115.1	 (d,	 2JC-F	 =	 23.3	 Hz),	
114.9	(d,	3JC-F	=	7.9	Hz),	112.4	(d,	2JC-F	=	24.9	Hz),	36.2,	21.7.	
19F	NMR	(CDCl3,	471	MHz):	δ	–117.57	




















13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 171.4,	 145.5,	 138.9,	 134.4,	 131.0,	 129.4,	
127.5,	127.4,	124.7,	117.2,	114.7,	35.3,	21.3.	










13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 172.7,	 157.0,	 145.6,	 135.2,	 133.8,	 129.8,	
127.9,	124.5,	114.5,	113.2,	111.2,	55.7,	36.5,	21.7.	





Prepared	 according	 to	 the	 general	 procedure	 from	 (1-tosyl-5-










HRMS	 (TOF):	 m/z	 [M+H]+	 calcd	 for	 C16H12F3NO4S:	 372.0517;	 found:	
372.0527.	
Methyl	2-oxo-1-tosylindoline-5-carboxylate	(3i)	
Prepared	 according	 to	 the	 general	 procedure	 from	 (5-







13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 171.9,	 165.8,	 145.6,	 143.6,	 134.4,	 130.2,	
129.4,	127.6,	126.1,	125.5,	122.8,	112.8,	51.8,	35.3,	21.3.	
HRMS	 (NSI):	 m/z	 [M+H]+	 calcd	 for	 C17H16NO5S:	 346.0744;	 found:	
346.0746.	
Benzofuran-2(3!)-one	(3k)25a	
Prepared	 according	 to	 the	 general	 procedure	 from	 benzofuran-2-














13C	 NMR	 (CDCl3,	 500	MHz):	 δ	 173.6,	 159.4	 (d,	 1JC-F	 =	 242.5	 Hz),	 150.6,	





A	 10	 mL	 flask	 was	 charged	 with	 sodium	 metal	 (138	 mg,	 6	 mmol,	 60	
equiv)	and	naphthalene	(385	mg,	3	mmol,	30	equiv)	before	the	addition	
of	 DME	 (5	 mL)	 and	 the	 reaction	 mixture	 was	 stirred	 at	 room	
temperature	 for	30	min	 to	 form	a	blue/green	solution.	A	 solution	of	1-
tosylindolin-2-one	 (28	mg,	 0.1	mmol,	 1	 equiv)	 in	DME	 (0.5	mL,	 0.2	M)	
was	cooled	to	–78	°C	and	the	Na-naphthalenide	solution	was	then	added	
dropwise	 until	 an	 orange/red	 colour	 persisted	 (1.5	 mL).	 The	 solution	
was	 then	 warmed	 to	 room	 temperature	 and	 a	 further	 0.5	 mL	 na-
naphthalenide	solution	was	added.	The	reaction	was	then	quenched	with	
H2O	(2	mL),	extracted	with	EtOAc	(5	mL),	and	washed	with	brine	(5	mL).	
The	 organics	 were	 then	 passed	 through	 a	 hydrophobic	 frit	 and	
concentrated	 under	 vacuum	 before	 being	 purified	 (silica	 gel,	 10-40%	










before	 the	 addition	 of	 EtOH	 (10	 mL,	 0.5	 M).	 Piperidine	 (12	 µL,	 0.01	
mmol,	 0.01	 equiv)	was	 then	 added	 and	 the	 flask	was	 equipped	with	 a	
condenser	 before	 heating	 to	 reflux	 for	 4	 h.	 The	 reaction	 mixture	 was	
then	 cooled	 to	 room	 temperature	 and	 concentrated	 under	 vacuum	 to	
afford	a	red/orange	solid.	The	precipitate	was	collected	by	filtration	and	








13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 169.8,	 137.0,	 136.9,	 132.6,	 127.1,	 126.6,	
125.6,	123.6,	121.5,	117.4,	112.7,	111.8,	109.2,	13.9,	11.6.			
HRMS	 (NSI):	 m/z	 [M+H]+	 calcd	 for	 C15H15N2O:	 239.1179;	 found:	
239.1177.	
Spiro[cyclopropane-1,3'-indolin]-2'-one	(8)	
An	 oven	 dried	 flask	 was	 charged	 with	 oxindole	 (133	 mg,	 1	 mmol,	 1	
equiv)	 before	 the	 addition	 of	 dry	 DMF	 (1.25	 mL,	 0.8	 M)	 and	
dibromoethane	 (94	 µL,	 1.1	 mmol,	 1.1	 equiv).	 The	 solution	 was	 then	
cooled	to	0	°C	before	the	addition	of	NaH	(60%	dispersion	in	mineral	oil,	
180	 mg,	 4.5	 mmol,	 4.5	 equiv)	 portionwise	 over	 20	 min.	 The	 reaction	
mixture	was	 then	warmed	 to	 room	 temperature	 and	 stirred	 overnight	
before	 being	 quenched	 with	 H2O	 (3	 mL)	 and	 extracted	 with	 EtOAc	 (5	
mL).	The	organics	were	then	washed	with	H2O	(2	×	5	mL)	and	brine	(2	×	
5	mL).	 The	 organics	were	 then	 passed	 through	 a	 hydrophobic	 frit	 and	
concentrated	 under	 vacuum	 before	 being	 purified	 (silica	 gel,	 20-40%	










A	 5	mL	microwave	 vial	 equipped	with	 a	 stirrer	 bar	 was	 charged	with	
spiro[cyclopropane-1,3'-indolin]-2'-one	 (20	 mg,	 0.125	 mmol,	 1	 equiv)	
and	MgI2	(1.74	mg,	6.25	µmol,	5	mol%)	before	being	capped	and	purged	




with	 H2O	 (5	 mL)	 and	 brine	 (5	 mL).	 The	 organics	 were	 then	 passed	
through	a	hydrophobic	frit	and	concentrated	under	vacuum	before	being	
purified	 (silica	 gel,	 50%	 EtOAc/petroleum	 ether	 followed	 by	 20%	









13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 182.7,	 140.1,	 136.0,	 127.8,	 123.4,	 122.9,	
109.5,	66.2,	56.7,	53.6,	41.8,	38.0.	






form	a	blue/green	 solution.	A	 solution	of	 5-chloro-1-tosylindolin-2-one	
(20	mg,	0.06	mmol,	1	equiv)	in	DME	(0.3	mL,	0.2	M)	was	cooled	to	-78	°C	




EtOAc	 (5	mL),	 and	washed	with	 brine	 (5	mL).	 The	 organics	were	 then	
passed	 through	 a	 hydrophobic	 frit	 and	 concentrated	 under	 vacuum	






13C	 NMR	 (CDCl3,	 101	MHz):	 δ	 175.5,	 139.8,	 127.0,	 126.7,	 125.9,	 124.1,	
109.4,	35.0.	
HRMS	 (NSI):	 m/z	 [M+H]+	 calcd	 for	 C8H7ClNO:	 168.0211;	 found:	
168.0207.	
Phenyl	5-chloro-2-oxoindoline-1-carboxylate	(10)	
Step	 1:	 Phenyl	 5-chloro-2-((phenoxycarbonyl)oxy)-1H-indole-1-
carboxylate.	
To	a	 flask	charged	with	5-chloro-2-oxindole	(1	g,	6	mmol,	1	equiv)	was	
added	20	mL	dry	THF	 followed	by	 triethylamine	 (1.75	mL,	 12.6	mmol,	
2.1	equiv).	The	reaction	mixture	was	cooled	to	0	°C	before	the	dropwise	
addition	 of	 phenyl	 chloroformate	 (1.6	 mL,	 13.2	 mmol,	 2.2	 equiv).	 The	
mixture	was	 stirred	 at	 0	 °C	 for	 1	 h.	 The	 resulting	precipitate	was	 then	




the	 filter	 cake	 to	 afford	 the	 desired	 product	 phenyl	 5-chloro-2-
((phenoxycarbonyl)oxy)-1H-indole-1-carboxylate.	 Yield:	 2.4	 g	 (crude	
weight).	 White	 solid.	 The	 product	 was	 used	 directly	 in	 the	 next	 step	
without	further	purification.	
Step	2	
A	 solution	 of	 phenyl	 5-chloro-2-((phenoxycarbonyl)oxy)-1H-indole-1-
carboxylate	(1.11	g,	2.75	mmol,	1	equiv)	in	dry	DMF	(10	mL)	was	cooled	
to	 0	 °C,	 followed	 by	 the	 portionwise	 addition	 of	 ammonium	 carbonate	
powder	 (300	 mg,	 3.16	 mmol,	 1.15	 equiv).	 The	 resulting	 solution	 was	
stirred	for	1	h	at	0	°C.	Upon	consumption	of	the	starting	material	the	pale	
yellow	solution	was	then	poured	into	30	mL	ice	water	to	provide	a	white	







13C	 NMR	 (CDCl3,	 126	MHz):	 δ	 171.5,	 150.0,	 149.4,	 138.9,	 130.5,	 129.7,	
128.5,	126.6,	125.0,	124.6,	121.5,	116.7,	36.3.	
HRMS	 (NSI):	 m/z	 [M+H]+	 calcd	 for	 C15H11ClNO3:	 288.0422;	 found:	
288.0423.	
Tenidap	
Step	 1:	 Phenyl	 (E)-5-chloro-3-(hydroxy(thiophen-2-yl)methylene)-2-
oxoindoline-1-carboxylate	(11).	To	a	50	mL	flask	charged	with	phenyl	5-
chloro-2-oxoindoline-1-carboxylate	(100	mg,	0.35	mmol,	1	equiv)	and	4-
dimethylaminopyridine	 10.7	 g	 (74	 mg,	 0.735	 mmol,	 2.1	 equiv)	 was	
added	anhydrous	DMF	(1.4	mL,	0.25	M),	and	cooled	to	0	°C.	A	solution	of	
thiophene-2-carbonyl	 chloride	 (56	 mg,	 0.385	 mmol,	 1.1	 equiv)	 in	 dry	
DMF	 (0.6	mL)	was	 then	 added	 dropwise	 and	 the	 resulting	 suspension	
was	stirred	at	0	°C	until	consumption	of	the	starting	material	(approx.	1	
h).	The	solution	was	then	poured	into	3	mL	ice	water,	acidified	to	pH	2–3	
with	 concentrated	 hydrochloric	 acid	 and	 stirred	 for	 3	 h.	 The	 resulting	
precipitate	was	then	filtrated,	washed	with	H2O	(2×5	mL),	and	dried	by	
drawing	 air	 through	 the	 filter	 cake	 to	 afford	 the	 desired	 product	 11.	
Yield:	111	mg	 (crude	weight).	 Pale	 yellow	solid.	The	product	was	used	
directly	in	the	next	step	without	further	purification.	




for	 4	 h.	 The	 reaction	 mixture	 was	 then	 cooled	 to	 room	 temperature	
before	 being	 diluted	with	 EtOAc	 (5	mL)	 and	washed	with	H2O	 (5	mL).	
The	 organics	 were	 then	 passed	 through	 a	 hydrophobic	 frit	 and	







13C	NMR	 (DMSO,	 101	MHz):	 δ	 176.8,	 165.7,	 154.7,	 149.1,	 132.0,	 130.1,	
129.5,	129.1,	126.9,	126.0,	118.3,	117.3,	113.9,	94.3.	
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0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
f1 (ppm)
-2000
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
24000
26000
28000
30000
32000
34000
 21
&105RIO
)105RIO
 

0102030405060708090100110120130140150160170180190200
f1 (ppm)
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
7000
7500
8000
8500
-220-210-200-190-180-170-160-150-140-130-120-110-100-90-80-70-60-50-40-30-20-1001020
f1 (ppm)
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
 22
+105RI  

&105RI

0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
f1 (ppm)
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
0102030405060708090100110120130140150160170180190200
f1 (ppm)
-2000
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
12000
13000
14000
15000
16000
17000
18000
19000
20000
21000
22000
23000
 23
+105RIVHPD[DQLE  


&105RIVHPD[DQLE

0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.511.512.513.5
f1 (ppm)
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
0102030405060708090100110120130140150160170
f1 (ppm)
-5000
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
55000
60000
65000
70000
 24


+105RI
&105RI

0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
-2000
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
12000
13000
14000
15000
16000
17000
18000
19000
20000
21000
22000
23000
24000
0102030405060708090100110120130140150160170180190
f1 (ppm)
-10000
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
1E+05
1E+05
1E+05
 25
+105RIFRHUXOHVFLQH
&105RIFRHUXOHVFLQH

0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
7000
7500
8000
0102030405060708090100110120130140150160170180190200
f1 (ppm)
-20000
-10000
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
1E+05
1E+05
1E+05
1E+05
1E+05
2E+05
2E+05
2E+05
2E+05
2E+05
2E+05
1+
2
  FRHUXOHVFLQH
1 0H
 26
+105RI
&105RI


0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
f1 (ppm)
-2000
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
12000
13000
14000
15000
16000
17000
18000
19000
20000
21000
22000
23000
0102030405060708090100110120130140150160170180190
f1 (ppm)
-10000
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
1E+05
1E+05
1E+05
1E+05
 27
+105RI
&105RI


0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
f1 (ppm)
-500
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
5500
6000
6500
0102030405060708090100110120130140150160170180190200
f1 (ppm)
-2000
0
2000
4000
6000
8000
10000
12000
14000
16000
18000
20000
22000
24000
26000
28000
30000
32000
 28
+105RIWHQLGDS
&105RIWHQLGDS

 
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
f1 (ppm)
-2000
-1000
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
11000
12000
13000
14000
15000
16000
17000
18000
19000
20000
21000
22000
0102030405060708090100110120130140150160170180190200
f1 (ppm)
-5000
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
50000
55000
60000
65000
70000
75000
80000
